A Study to Evaluate of Cosmetic Benefit of a Moisturising Cream in People With Blemish Prone Skin

NACompletedINTERVENTIONAL
Enrollment

157

Participants

Timeline

Start Date

April 4, 2017

Primary Completion Date

August 28, 2017

Study Completion Date

August 28, 2017

Conditions
Skin Care
Interventions
OTHER

Washout / Standard Cleanser

Participants will apply standard cleanser (Simple Kind to Skin Moisturising Facial Wash) twice daily (morning and night) with at least 8 hours between product applications. Participants will use the standard cleanser in a 5-7 day washout period and during the test phase of the study

OTHER

Test product

Participants will apply 0.6 gram (g) of Test product (Moisturising Cream with Niacinamide) twice daily (morning and night) with at least 8 hours between product applications. Participants will use the test product during the test phase of the study.

OTHER

Positive control cleanser

Participants will apply positive control cleanser (Neutrogena Visibly Clear Spot Clearing Facial Wash) twice daily (morning and night) with at least 8 hours between product applications. Participants will use the positive control cleanser during the test phase of the study.

OTHER

Positive control moisturiser

Participants will apply 0.6 g of positive control moisturiser (Vivatinell Acnecinamide Gel Cream) twice daily (morning and night) with at least 8 hours between product applications. Participants will use the positive control moisturiser during the test phase of the study.

Trial Locations (1)

13271-130

GSK Investigational Site, Valinhos

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT03093181 - A Study to Evaluate of Cosmetic Benefit of a Moisturising Cream in People With Blemish Prone Skin | Biotech Hunter | Biotech Hunter